Cellular Target Profiling & Phosphoproteomic Overview

The Integration of Kinaxo's novel technologies enables Evotec and its partners to take earlier educated decisions on drug efficacy, safety and response in patients. Kinaxo's capabilities comprise a unique combination of innovative technologies improving drug development across the entire pharma value chain:

-       Cellular Target Profiling^® uncovers the molecular targets of compounds with unknown mode-of-action and reveals possible off-target side effects early in the discovery and development process.

-       KinAffinity^® determines the cellular selectivity of kinase inhibitors, which represent the most important class of targeted cancer drugs.

-       PhosphoScout^® provides valuable knowledge on drug modes-of-action in vivo and how they respond to drug treatment. 

For more information please visit the Kinaxo Website or contact us at info@evotec.com